ShareValue scores for GSS.AU: Valuation 71, Quality 53, Growth 43, Health 49.

GSS.AU
ASX

Genetic Signatures Ltd

A$0.06(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

14% to 28%
Valuation
71
Undervalued
Price vs Value
Quality
53
Moderate
Business Strength
Growth
43
Moderate
Revenue & Earnings
Health
49
Moderate
Financial Stability
Momentum
28
Bearish
Price Trend

Company Details

About

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. It offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. The company was incorporated in 2001 and is headquartered in Newtown, Australia.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026